Part | Jotup

Summa Silver Announces $10 Million Brokered Financing

Retrieved on:

Monday, December 19, 2022

Part, Person, NI, TSX Venture Exchange, News, Unit, Indian stock exchange, Regulation, National instrument, Offering, Agent, NOT, FOR, Sale, Security (finance)

VANCOUVER, British Columbia, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Summa Silver Corp. (“Summa” or the “Company”) (TSXV:SSVR) (OTCQB: SSVRF) (Frankfurt:48X) is pleased to announce that it has entered into an agreement with Research Capital Corporation and Eventus Capital Corp., as co-lead agents and joint bookrunners, on behalf of a syndicate of agents (collectively, the "Agents") in connection with a brokered private placement financing (the "Offering") of up to 12,500,000 units (each, a “Unit”) at a price of $0.80 per Unit, for aggregate gross proceeds of up to $10 million.

Key Points:

Galen McNamara, CEO of the Company, stated: “I would like to thank our shareholders and welcome new shareholders for their support and endorsement of the Company.
In less than three years since inception, we have come a long way on both of our landmark American high-grade silver projects.
The Offering is anticipated to close on or about December 29, 2022, or such later date as the Company may determine.
The Company has agreed to pay to the Agents a cash commission equal to 6% of the gross proceeds of the Offering.

XORTX Announces Completion of Dosing in XRX-OXY-101 Clinical Study

Retrieved on:

Monday, December 19, 2022

Clinical, Autosome, Part, ADPKD, Pharmacokinetics, Therapy, Polycystic kidney disease, Kidney disease, Control, FDA, XRX, 2013 Bendigo Women's International (2) – Singles, Marketing, Regulation, Pharmaceutical industry, Chemistry, EU

CALGARY, Alberta, Dec. 19, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce the completion of dosing in the XRX-OXY-101 pharmacokinetics bridging study (the “Study”).

Key Points:

CALGARY, Alberta, Dec. 19, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce the completion of dosing in the XRX-OXY-101 pharmacokinetics bridging study (the “Study”).
Previously topline results from Part 1 and 2 have been reported in the Company’s press releases of July 13 and August 22, 2022.
Plasma sample analysis and topline results from both part 3 and part 4 are expected within the next several weeks.
Consolidated topline results from each part are anticipated to be reported in January 2023.

MAIA Biotechnology to Participate in Four Upcoming Investor Conferences

Retrieved on:

Thursday, January 5, 2023

MAIA Biotechnology, Inc. (NYSE American: MAIA ) (“MAIA,” “the Company”) announced today that the management team will participate in the four upcoming investor conferences as follows:

Key Points:

MAIA Biotechnology, Inc. (NYSE American: MAIA ) (“MAIA,” “the Company”) announced today that the management team will participate in the four upcoming investor conferences as follows:
Biotech Showcase: The Investor Conference for Innovators will be held in-person in San Francisco from January 9-11, and virtually from January 18-19.
The MAIA team will host investor meetings and is scheduled to present on Monday, January 9 at 4:00 pm PT.
The MAIA team will conduct investor meetings at this event.
BIO CEO & Investor Conference will be held in-person in New York City from February 6-7 and virtually from February 8-9.

Nostromo Energy Reaches Key Application Milestone for $189 Million Loan Guarantee from the U.S. Department of Energy to Deploy 275 MWh of Distributed Energy Storage Systems

Retrieved on:

Wednesday, January 4, 2023

The proposed $189 million loan guarantee from the DOE would support Nostromo’s “energy storage-as-a-service” (ESaaS) offering, designed to accelerate the deployment of its large-scale, behind-the-meter, modular and highly-efficient cold energy storage technology.

Key Points:

The proposed $189 million loan guarantee from the DOE would support Nostromo’s “energy storage-as-a-service” (ESaaS) offering, designed to accelerate the deployment of its large-scale, behind-the-meter, modular and highly-efficient cold energy storage technology.
The loan guarantee is subject to completion of an equity capital raise for an amount yet to be determined.
Concurrently, Nostromo appointed investment bank Independence Point Securities as an exclusive advisor for raising the equity capital for the project.
To date, LPO’s Title XVII Innovative Clean Energy Loan Guarantee Program has provided more than $35 billion in loan guarantees to a variety of energy projects.

Québec Nickel Corp. Announces Closing of the Second Tranche of Its Previously Announced Private Placement

Retrieved on:

Friday, December 30, 2022

Mining, Minerals, Natural Resources, QC, Warrant, Income Tax Act, Part, Income Tax Act 1967, Canadian Securities Exchange, Unit, Indian stock exchange, CSE, National instrument, Substantial shareholdings exemption, QNI, Security (finance)

The total proceeds raised from both the first and Second Tranche of the previously announced private placement is $8,695,288.08.

Key Points:

The total proceeds raised from both the first and Second Tranche of the previously announced private placement is $8,695,288.08.
All National and QC FT Shares issued in the private placement are subject to a four-month hold period expiring on April 30, 2023.
The Company is pleased to have received support and participation from its existing shareholders in the private placement.
As a result of the closing of the private placement, there are now 110,842,205 common shares of the Company issued and outstanding.

21 CFR Part 11, SaaS/Cloud, EU GDPR Course: Reduce Costs for Compliance with Data Integrity (February 1-2, 2023) - ResearchAndMarkets.com

Retrieved on:

Thursday, December 29, 2022

Software, Technology, Online Privacy, Data Management, Cloud, Clinical trial, Software, GxP, Part, Software as a service, Computer, Title 21 CFR Part 11, Verification and validation, FDA, Medical device, EU

The "Reduce costs for compliance with data integrity: 21 CFR Part 11, SaaS/Cloud, EU GDPR" training has been added to ResearchAndMarkets.com's offering.

Key Points:

The "Reduce costs for compliance with data integrity: 21 CFR Part 11, SaaS/Cloud, EU GDPR" training has been added to ResearchAndMarkets.com's offering.
It details the requirements for Part 11 and Annex 11: SOPs, software product features, infrastructure qualification, and validation.
The instructor addresses the latest computer system industry standards for data security, data transfer, audit trails, electronic records and signatures, software validation, and computer system validation.
Participants learn how to decrease software implementation times and lower costs using a 10-step risk-based approach to computer system validation.

The Commonwealth of Massachusetts Selects NWN Carousel to Provide Cloud Contact Center Services via the MassVoice Contract

Retrieved on:

Thursday, December 22, 2022

NWN Carousel , a leading Cloud Communications Service Provider (CCSP) delivering solutions for today’s work-from-anywhere environment, has been awarded Part 3 of the MassVoice contract for Virtual Cloud Contact Center services by the Baker-Polito Administration.

Key Points:

NWN Carousel , a leading Cloud Communications Service Provider (CCSP) delivering solutions for today’s work-from-anywhere environment, has been awarded Part 3 of the MassVoice contract for Virtual Cloud Contact Center services by the Baker-Polito Administration.
Under the ITT72 contract, the Commonwealth of Massachusetts’ statewide IT contract, the new MassVoice platform provides NWN Carousel’s integrated as-a-service cloud contact center solutions delivered on the Five9 platform.
Partnering with the Executive Office of Technology Services and Security (EOTSS), NWN Carousel will assist several state agencies in Massachusetts transition their contact center services to the cloud.
And most recently, NWN Carousel helped The State of Florida launch a new cloud contact center to provide essential services in the wake of Hurricane Ian.

Montage Technology PCIe 5.0/CXL 2.0 Retimer Chip Achieves Mass Production

Retrieved on:

Friday, January 6, 2023

SHANGHAI, Jan. 6, 2023 /PRNewswire/ -- Montage Technology, a leading data processing and interconnect IC design company, announced today that its PCIe 5.0/CXL 2.0 Retimer has successfully achieved mass production.

Key Points:

SHANGHAI, Jan. 6, 2023 /PRNewswire/ -- Montage Technology, a leading data processing and interconnect IC design company, announced today that its PCIe 5.0/CXL 2.0 Retimer has successfully achieved mass production.
This chip is a key upgrade based on Montage's PCIe 4.0 Retimer, providing a stable and reliable PCIe 5.0 and CXL 2.0 interconnect solution with high bandwidth and low latency for the cloud and high-performance computing market.
Montage's PCIe 5.0/CXL 2.0 Retimer employs advanced signal conditioning technologies to improve signal integrity and increase the effective transmission distance of high-speed signals.
Montage Technology's 16-lane PCIe 5.0/CXL 2.0 Retimer (Part Number: M88RT51632) is available for purchase now.

Pusan National University Researchers Develop Efficient Sodium-Ion Battery Anode for Energy Storage

Retrieved on:

Friday, January 6, 2023

Lithium, Part, Electronics, SIB, Sodium, Pyrolysis, Sibs, Climate change, Chemical substance, Ion, Kinetics, Carbon, Pusan National University, Chemical engineering, Electric battery

Researchers from Korea and USA have recently developed pyrolyzed quinacridones, new carbonaceous SIB anode materials, that are efficient, easily prepared, and exhibit excellent electrochemical properties, including high sodium-ion storage performance and cycling stability.

Key Points:

Researchers from Korea and USA have recently developed pyrolyzed quinacridones, new carbonaceous SIB anode materials, that are efficient, easily prepared, and exhibit excellent electrochemical properties, including high sodium-ion storage performance and cycling stability.
It is necessary to reduce carbon emissions by utilizing renewable energy sources and developing efficient energy storage systems.
Recently, a team of researchers, led by Professor Seung Geol Lee from Pusan National University in Korea, used quinacridones as precursors to prepare carbonaceous SIB anodes.
Given the high efficiency, they will provide an effective strategy for mass production of large-scale energy storage systems," concludes Prof. Lee.

Apollo Medical Holdings, Inc. Announces APA ACO Achieved $48.8 Million in Shared Savings from Centers for Medicare and Medicaid Services for 2021 Performance Year

Retrieved on:

Thursday, January 5, 2023

Part, Model, CMS, Direct, Next Generation, ACO, Risk, Centers for Medicare & Medicaid Services, Patient, APA, Medicare Part D coverage gap, Medicare (United States), Medicare, Health insurance

In 2016, APA ACO applied for and was approved by CMS to participate in the Next Generation Accountable Care Organization (ACO) Model.

Key Points:

In 2016, APA ACO applied for and was approved by CMS to participate in the Next Generation Accountable Care Organization (ACO) Model.
APA ACO was approved to participate in the All-Inclusive Population-Based Payment ("AIPBP") track, which was the most advanced risk-taking payment model.
For 2021, APA ACO's aggregate benchmark expenditure was $437.2 million, with actual expenditures amounting to $381.1 million, resulting in gross savings of $56.2 million.
The Company elected the 80/20 risk arrangement with CMS in 2021, the Next Generation ACO's final performance year, which allowed APA ACO to retain 15% of its gross shared savings, or $48.8 million.